Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

A kind of synthetic method of the intermediate of Sofosbuvir

A synthesis method and a technology for intermediates, applied in the field of synthesis of pharmaceutical intermediates, can solve problems such as hair loss, thinning of nails, sensitization of sodium hypochlorite, etc., and achieve the effects of increasing reaction intensity, saving production costs, and huge industrial production prospects.

Active Publication Date: 2022-06-24
JIANGSU COBEN PHARMA CO LTD
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The oxidizing agent that this reaction is used is sodium hypochlorite or sodium periodate, and the shortcoming that it shows is: sodium periodate is irritating to eyes, upper respiratory tract, mucous membrane and skin, needs to wear suitable protective clothing, gloves and Use protective glasses or face shields; sodium hypochlorite is absorbed through inhalation, ingestion, and skin contact. Workers who often touch sodium hypochlorite with their hands will sweat profusely in their palms, their nails will become thinner, and their hair will fall off.
When sodium hypochlorite or sodium periodate is used for oxidation reaction, there will be by-products NaCl or NaI, which is not conducive to subsequent processing

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of synthetic method of the intermediate of Sofosbuvir
  • A kind of synthetic method of the intermediate of Sofosbuvir
  • A kind of synthetic method of the intermediate of Sofosbuvir

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] A kind of synthetic method of sofosbuvir intermediate (I), concrete steps are as follows:

[0027] Step 1, synthesis of compound (III): under the condition of 0~5℃, add compound (II) 24.8g (0.1mol), dichloromethane 200g and triethylamine 20.2g (0.2mol) into a dry three-necked flask, stir To 0°C, slowly add 17.9g (0.15mol) of thionyl chloride dropwise, after 30min of reaction, add 100g of ice water, 200g of dichloromethane, stir for 30min, separate the organic layer, and then use 100g of water and 20% The organic layer was washed with brine to obtain a dichloromethane solution of compound (III).

[0028] Step 2: Synthesis of compound (IV): add 1.65 g (0.05 mol) of sodium tungstate dihydrate to the dichloromethane solution of compound (III) in step one, and add 28.3 g of 30% hydrogen peroxide dropwise at 23° C. (0.25mol), continue to react for 9h after dripping until compound (III) disappears, filter and recover sodium tungstate dihydrate, and the filtrate is washed with...

Embodiment 2

[0033] A kind of synthetic method of sofosbuvir intermediate (I), concrete steps are as follows:

[0034] Step 1, synthesis of compound (III): under the condition of 0~5℃, add compound (II) 22.6g (0.09mol), dichloromethane 180g and triethylamine 18.2g (0.18mol) into a dry three-necked flask, stir To 0°C, slowly add 15.5g (0.13mol) of thionyl chloride dropwise, after 20min of reaction, add 100g of ice water, 200g of dichloromethane, stir for 30min, separate the organic layer, and then use 100g of water and 20% The organic layer was washed with brine to obtain a dichloromethane solution of compound (III).

[0035]Step 2, the synthesis of compound (IV): add 15 g (0.045 mol) of sodium tungstate dihydrate to the dichloromethane solution of the compound (III) in step one, and at 20° C., add dropwise 26.4 g of 35% hydrogen peroxide ( 0.27mol), continue to react for 8h until compound (III) disappears after dropping, and recover sodium tungstate dihydrate by filtration. The filtrate i...

Embodiment 3

[0040] A kind of synthetic method of sofosbuvir intermediate (I), concrete steps are as follows:

[0041] Step 1, the synthesis of compound (III): under low temperature conditions, add compound (II) 29.76g (0.12mol), dichloromethane 230g and triethylamine 21.2g (0.21mol) into a dry three-necked flask, stir to 0°C , slowly add 18.6g (0.156mol) of thionyl chloride dropwise, after 40min of reaction, add 100g of ice water, 200g of dichloromethane, stir for 30min, separate the organic layer, then wash with 100g of water and 20% brine respectively The organic layer was obtained as a dichloromethane solution of compound (III).

[0042] Step 2, the synthesis of compound (IV): add 1.75 g (0.053 mol) of sodium tungstate dihydrate to the dichloromethane solution of compound (III) in step one, and add 29.9 g of 25% hydrogen peroxide dropwise at 25°C (0.22mol), continue to react for 10h after dripping until compound (III) disappears, filter and recover sodium tungstate dihydrate, and the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a kind of synthetic method of sofosbuvir intermediate shown in formula (I): the present invention uses compound (2S,3R)-ethyl-3-((R)-2,2-dimethyl Base-1,3-dioxolane-4-yl)-2,3-dihydroxy-2-methyl propionate (Ⅱ) as starting material, through thionyl chloride cyclization to form compound (Ⅲ ), then compound (Ⅲ) was oxidized by hydrogen peroxide / sodium tungstate to obtain compound (Ⅳ), and compound (Ⅳ) was fluorinated, hydrolyzed and benzoylated to synthesize sofosbuvir intermediate 3,5-di Benzoyl-2-deoxy-2-fluoro-2methyl-D-ribose-γ-lactone (I), the sofosbuvir intermediate synthesized by the present invention is environmentally friendly and economical, and has huge industrial production prospects.

Description

technical field [0001] The invention relates to a method for synthesizing a pharmaceutical intermediate, in particular to a method for synthesizing an intermediate of sofosbuvir. [0002] technical background [0003] Sofosbuvir (also translated as Sofosbuvir, English name Sofosbuvir, trade name Sovaldi) is a new drug developed by Gilead for the treatment of chronic hepatitis C. It was approved by the U.S. Food and Drug Administration (FDA) on December 6, 2013. ) was approved for marketing in the United States, and was approved for marketing in EU countries by the European Medicines Agency (EMEA) on January 16, 2014. Not yet listed in China. The drug is the first to safely and effectively treat some types of hepatitis C without the need for combined interferon. Clinical trials have demonstrated an overall sustained virological response rate (SVR) of up to 90% in combination with peginterferon and ribavirin for hepatitis C type 1 and 4; for hepatitis C type 2, the drug in co...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D307/33
CPCC07D307/33
Inventor 游金宗蒋善会史磊胡建隆何牮石
Owner JIANGSU COBEN PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com